[go: up one dir, main page]

PT70064A - Process for preparing compounds with anti-inflammatory activity - Google Patents

Process for preparing compounds with anti-inflammatory activity

Info

Publication number
PT70064A
PT70064A PT70064A PT7006479A PT70064A PT 70064 A PT70064 A PT 70064A PT 70064 A PT70064 A PT 70064A PT 7006479 A PT7006479 A PT 7006479A PT 70064 A PT70064 A PT 70064A
Authority
PT
Portugal
Prior art keywords
inflammatory activity
preparing compounds
preparing
compounds
inflammatory
Prior art date
Application number
PT70064A
Other languages
English (en)
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of PT70064A publication Critical patent/PT70064A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT70064A 1978-08-15 1979-08-14 Process for preparing compounds with anti-inflammatory activity PT70064A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7833431 1978-08-15
GB7848348 1978-12-13

Publications (1)

Publication Number Publication Date
PT70064A true PT70064A (en) 1979-09-01

Family

ID=26268543

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70064A PT70064A (en) 1978-08-15 1979-08-14 Process for preparing compounds with anti-inflammatory activity

Country Status (9)

Country Link
US (1) US4296114A (pt)
EP (1) EP0008864A1 (pt)
AU (1) AU4985379A (pt)
DK (1) DK338379A (pt)
FI (1) FI792507A (pt)
GR (1) GR69706B (pt)
IL (1) IL58038A0 (pt)
NO (1) NO792653L (pt)
PT (1) PT70064A (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030795A3 (en) * 1979-12-06 1981-09-09 Imperial Chemical Industries Plc Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
DE3032994A1 (de) * 1980-09-02 1982-04-22 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pyrazino-azepine, deren herstellung und diese sie enthaltende arzneimittel
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
JPS62281878A (ja) * 1986-02-26 1987-12-07 Taisho Pharmaceut Co Ltd アザアントラセン化合物
JPH0678319B2 (ja) * 1986-03-11 1994-10-05 東ソー株式会社 キノキサリノン誘導体
JPS6450868A (en) * 1987-08-21 1989-02-27 Toyo Jozo Kk 1-substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivative
JPH0276860A (ja) * 1987-10-05 1990-03-16 Toyo Jozo Co Ltd 6−置換アルコキシ−2−オキソ−1,2−ジヒドロキノキサリン誘導体
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
GB9413975D0 (en) 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
WO1992011245A1 (en) * 1990-12-20 1992-07-09 Warner-Lambert Company 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
FR2696456B1 (fr) * 1992-10-07 1995-01-06 Pf Medicament Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
US5620978A (en) * 1994-01-03 1997-04-15 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
GB2291422A (en) * 1994-07-18 1996-01-24 Fujisawa Pharmaceutical Co 4-phenyl-pyrido[2,3-b]pyrazin-4-ones
FR2731221B1 (fr) * 1995-03-01 1997-05-30 Pf Medicament Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
GB9526558D0 (en) * 1995-12-27 1996-02-28 Fujisawa Pharmaceutical Co Heterobicyclic derivatives
ZA973884B (en) * 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
EP1380298A3 (en) * 1996-05-23 2004-04-07 Bristol-Myers Squibb Pharma Company Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation
US5869487A (en) * 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
US6087373A (en) * 1997-09-23 2000-07-11 Merck & Co., Inc. Thrombin inhibitors
AU5758199A (en) * 1998-09-29 2000-04-17 Fujisawa Pharmaceutical Co., Ltd. Novel salts of pyridopyrazine compound and crystals thereof
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
AU5451400A (en) 1999-06-04 2000-12-28 Merck & Co., Inc. Thrombin inhibitors
PL366577A1 (en) * 2001-05-14 2005-02-07 Bristol-Myers Squibb Pharma Company Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
SE0302324D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
SE0302323D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
CN1886389B (zh) * 2003-09-30 2010-07-21 詹森药业有限公司 喹喔啉化合物
EP1685115A1 (en) * 2003-11-03 2006-08-02 Warner-Lambert Company LLC Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
KR20060130159A (ko) * 2004-01-06 2006-12-18 얀센 파마슈티카 엔.브이. 당뇨병 및 비만증 치료용 글리코겐 인산화효소억제제로서의(3-옥소-3,4-디하이드로-퀴녹살린-2-일-아미노)-벤즈아미드유도체 및 관련 화합물
JP2008509212A (ja) * 2004-08-09 2008-03-27 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 中枢神経系障害の治療のための新規なキノキサリノンノルエピネフリン再吸収阻害剤
US7601716B2 (en) * 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
DE102007050673A1 (de) 2007-10-19 2009-04-23 Friedrich-Schiller-Universität Jena Neue Hexaaza-acene und Verfahren zu ihrer Herstellung
TW200924770A (en) 2007-11-06 2009-06-16 Astrazeneca Ab Novel compounds 089
JP5735806B2 (ja) 2008-03-05 2015-06-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ピリドピラジノン誘導体インスリン分泌刺激剤、それらを得る方法および糖尿病を治療するためのそれらの使用
KR101637381B1 (ko) 2008-03-05 2016-07-07 메르크 파텐트 게엠베하 인슐린 분비 자극제들로서의 피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
US8859803B2 (en) 2009-06-26 2014-10-14 Ihara Chemical Industry Co., Ltd. Process for production of ketomalonic acid compounds or hydrates thereof
KR20120099639A (ko) 2009-10-02 2012-09-11 아스트라제네카 아베 호중구 엘라스타제의 억제제로서 사용되는 2-피리돈 화합물
JP5921500B2 (ja) 2013-07-19 2016-05-24 イハラケミカル工業株式会社 ケトマロン酸化合物の製造方法
KR102134407B1 (ko) 2014-02-17 2020-07-15 구미아이 가가쿠 고교 가부시키가이샤 유통 반응기를 사용한 케토말론산 화합물의 연속 제조방법
NZ743725A (en) * 2015-12-24 2024-11-29 Univ California Cftr regulators and methods of use thereof
AU2016379444B2 (en) 2015-12-24 2021-04-29 The Regents Of The University Of California CFTR regulators and methods of use thereof
EP3672598A4 (en) 2017-08-24 2021-04-28 The Regents of The University of California MEDICINAL COMPOSITIONS FOR THE EYE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1189552B (de) * 1959-07-03 1965-03-25 Donau Pharmazie Ges M B H Verfahren zur Herstellung von 2-Oxo-1, 2-dihydrochinoxalinen und von deren Salzen und quaternaeren Ammoniumverbindungen
US4077955A (en) * 1977-02-17 1978-03-07 E. R. Squibb & Sons, Inc. Amino derivatives of 1,2,3,4-tetrahydro-2-oxopyrido[2,2-b]-pyrazine carboxylic acids and esters

Also Published As

Publication number Publication date
GR69706B (pt) 1982-07-09
AU4985379A (en) 1980-02-21
US4296114A (en) 1981-10-20
DK338379A (da) 1980-02-16
EP0008864A1 (en) 1980-03-19
IL58038A0 (en) 1979-12-30
FI792507A (fi) 1980-02-16
NO792653L (no) 1980-02-18

Similar Documents

Publication Publication Date Title
PT70064A (en) Process for preparing compounds with anti-inflammatory activity
YU42297B (en) Process for preparing new acylanilines
YU164379A (en) Process for preparing new urea compounds
YU42191B (en) Process for preparing 2-chloro-6-nitroanilines
GB2018816B (en) Process for preparing hexamethyltetrahydronaphthalenes
PT69686A (en) Process for preparing nitro compounds
PT70313A (en) Process for preparing substituted 1-thia-3-aza-4-ones
HU187258B (en) Process for preparing compopunds with hypotensive activity
YU36779A (en) Process for preparing new substituted 2-phenylimino-imidazolidines
PT69663A (en) Process for the preparation of new derivatives of 5-nitro-imidazole with antiprotozoic activity
DE2962639D1 (en) Process for preparing 2-chlorosulfinyl-azetidinones
PT69183A (en) Process for preparing novel n-azolylalkyl-halogenoacetanilides with herbicidal activity
GB2019835B (en) Process for preparing n-carbamoyl-d-thienylglycines
PT69687A (en) Process for preparing nitro compounds
DE2961058D1 (en) Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides
DE2960047D1 (en) Process for preparing 2-oximinophenylacetonitrile
YU41093B (en) Process for preparing 6-deoxy-5hydroxy-tetracycline
YU215279A (en) Process for preparing new alpha-alkyl-o-oxybenzylamines
GB2019367A (en) Catalytic process for so
YU40533B (en) Process for preparing 2-bromoergosinine
DE2964629D1 (en) Process for preparing 3-amino-5-t-butylisoxazole
PT69691A (en) Process for preparing n-tritylimidazole compounds
DE2963897D1 (en) Process for preparing sodium-m-nitrobenzenesulfonate
PH15975A (en) Process for preparing cis-bicyclooctylamines
PT69287A (en) Process for preparing benzocycloheptapyrans